The Colton Consortium

The COLTON Consortium

Our benefactors, Judith and Stewart Colton’s extraordinary generosity has catalyzed the creation of the Colton Consortium:

The Colton Consortium—a partnership among the four Colton Centers at leading institutions including Penn, Yale, NYU, and Tel Aviv University—is a global initiative committed to transforming the prevention, diagnosis, treatment, and eventual cure of autoimmune disorders.

The mission of the Colton Consortium is to apply bold, collaborative, translational science to advance our mechanistic understanding of human autoimmunity. By engaging the most innovative scientists and physicians, the Consortium is committed to transforming discovery science, personalizing existing and novel therapies, and leveraging cutting-edge technology to better treat, cure, and prevent autoimmunity while improving patients’ health.